Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
3.24
-0.01 (-0.31%)
At close: Aug 21, 2025, 3:59 PM
3.24
0.00%
After-hours: Aug 21, 2025, 04:10 PM EDT

Cumberland Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
10.84M 11.71M 10.44M 9.09M 9.85M 8.5M 9.35M 10.09M 10.89M 9.22M 9.12M 11.41M 10.3M 11.18M 8.32M 8.07M 9.06M 10.54M
Cost of Revenue
2.01M 1.43M 1.98M 1.32M 2.85M 2.73M 2.73M 1.77M 1.52M 1.25M 2.65M 2.22M 2.03M 2.21M 3.33M 1.33M 1.74M 2.42M
Gross Profit
8.83M 10.29M 8.46M 7.76M 7M 5.77M 6.63M 8.32M 9.37M 7.97M 6.47M 9.19M 8.27M 8.96M 4.99M 6.74M 7.31M 8.12M
Operating Income
-747.48K 1.29M -1.84M -1.69M -1.24M -2.1M -2.09M -1.87M 22.86K 365.58K -2.28M -266.99K -1.85M -1.28M -4.35M -1.56M -1.44M -324.3K
Interest Income
127.49K 125.71K 106.67K 69.19K 61.84K 96.75K 81K 98.6K 57.06K 50.19K 45.7K 21.6K 15.07K 16.04K 6.67K 7.39K 6.59K 5.43K
Pretax Income
-729.54K 1.25M -1.96M -1.53M -1.09M -1.89M -6.28M -1.06M 869.09K 179.22K -2.41M -416.33K -1.36M -1.4M -4.38M -1.58M 732.14K -343.29K
Net Income
-740.74K 1.26M -1.9M -1.54M -1.09M -1.95M -6.29M -1.05M 872.2K 192.18K -2.46M -423.23K -1.36M -1.4M -3.85M -1.06M 1.23M 166.83K
Selling & General & Admin
7.1M 6.69M 7.55M 7.07M 7.01M 6.52M 8.2M 7.09M 7.04M 6.78M 6.89M 6.28M 6.76M 6.92M 6.72M 5.84M 6.22M 6.02M
Research & Development
1.47M 1.3M 1.29M 1.31M 1.06M 1.16M 1.26M 1.92M 1.15M 1.5M 1.41M 1.71M 1.82M 1.75M 1.61M 1.45M 1.36M 1.26M
Other Expenses
1.01M 1.01M 1.46M 1.08M 1.1M 1.11M 4.54M 1.18M 981.81K 1.23M 458.22K 1.49M 1.53M 1.59M 1.02M 1.01M 2.19M 1.17M
Operating Expenses
9.57M 9M 10.3M 9.46M 8.24M 7.87M 8.72M 10.19M 9.35M 9.51M 8.75M 9.48M 10.11M 10.26M 9.35M 8.31M 8.75M 8.44M
Interest Expense
109.55K 163.8K 223.26K 137.37K 126.35K 118.53K 178.79K 110.08K 192.63K 186.35K 179.46K 149.34K 137.62K 119.58K 27.73K 20.02K 25.86K 24.42K
Selling & Marketing Expenses
4.22M 4.23M 4.22M 4.4M 4.25M 4.15M 4.76M 4.74M 4.67M 4.28M 3.38M 4.11M 4.56M 4.61M 3.31M 3.8M 4.12M 3.79M
Cost & Expenses
11.58M 10.42M 12.28M 10.78M 11.09M 10.6M 11.44M 11.95M 10.87M 10.76M 11.4M 11.7M 12.15M 12.47M 12.67M 9.64M 10.49M 10.86M
Income Tax Expense
5.67K -5.67K -57K 11.44K 11.44K 11.44K 24.96K 6.94K 6.94K 6.94K 48.15K 6.9K 6.9K 6.9K 12.52K 7.46K 7.46K 7.46K
Shares Outstanding (Basic)
14.95M 14.94M 13.97M 14.05M 14.12M 14.1M 14.16M 14.28M 14.39M 14.36M 14.4M 14.48M 14.69M 14.69M 14.8M 14.88M 14.98M 14.97M
Shares Outstanding (Diluted)
15.27M 15.26M 13.97M 14.05M 14.12M 14.1M 14.16M 14.28M 14.55M 14.59M 14.4M 14.48M 14.69M 14.69M 14.8M 14.88M 15.11M 15.24M
EPS (Basic)
-0.05 0.08 -0.14 -0.11 -0.08 -0.14 -0.44 -0.07 0.06 0.01 -0.17 -0.03 -0.09 -0.1 -0.26 -0.07 0.08 0.01
EPS (Diluted)
-0.05 0.08 -0.14 -0.11 -0.08 -0.14 -0.44 -0.07 0.06 0.01 -0.17 -0.03 -0.09 -0.1 -0.26 -0.07 0.08 0.01
EBITDA
413.93K 2.73M 46.21K 13.07K 459.78K -336.63K -4.03M 299.9K 2.26M 1.62M -1.72M 1.28M 398.2K 377.79K -3.27M -482.33K 1.99M 908.73K
EBIT
-619.99K 1.42M -1.74M -1.39M -964.85K -1.77M -6.1M -946.2K 1.06M 365.57K -2.23M -266.99K -1.22M -1.28M -4.35M -1.56M 758K -318.87K
Depreciation & Amortization
1.03M 1.32M 1.78M 1.4M 1.42M 1.44M 2.07M 1.25M 1.2M 1.26M 511.48K 1.54M 1.62M 1.65M 1.08M 1.07M 1.23M 1.23M